Multiangle observations of Arctic clouds from FIRE ACE: June 3, 1998, case study

In May and June 1998 the Airborne Multiangle Imaging Spectroradiometer (AirMISR) participated in the FIRE Arctic Cloud Experiment (ACE). AirMISR is an airborne instrument for obtaining multiangle imagery similar to that of the satellite-borne MISR instrument. This paper presents a detailed analysis of the data collected on June 3, 1998. In particular, AirMISR radiance measurements are compared with measurements made by two other instruments, the Cloud Absorption Radiometer (CAR) and the MODIS airborne simulator (MAS), as well as to plane-parallel radiative transfer simulations. It is found that the AirMISR radiance measurements and albedo estimates compare favorably both with the other instruments and with the radiative transfer simulations. In addition to radiance and albedo, the multiangle AirMISR data can be used to obtain estimates of cloud top height using stereoimaging techniques. Comparison of AirMISR retrieved cloud top height (using the complete MISR-based stereoimaging approach) shows excellent agreement with the measurements from the airborne Cloud Lidar System (CLS) and ground-based millimeterwave cloud radar

Association of Lung cancer with Pneumonia and Chlamydia pneumoniae infection

Introduction: The degree of association and type of causal versus non-causal relationship between pneumonia and lung cancer (LC) are evolving discussions. We reviewed English publications on the degree of association between pneumonia and subsequent LC. Methods: We searched the PubMed database using key words for pneumonia, LC, and chlamydia infection. We selected peer-reviewed studies of patients with pneumonia and LC. Case reports and other literature reviews were excluded from this review. Results: Five studies examined the incidence and/or risk of LC for a total of 415,750 patients, and four studies examined cases with Chlamydia pneumoniae chronic infection at the time of diagnosis of LC for a total of 1,467 patients. The overall risk and/or incidence of LC after pneumonia was from 2.3% to 10% for a median follow-up ranging from 109 days to 4.2 years. Three studies reported current tobacco smoking status, which ranged from 27.7% to 45% among those with LC. A history of prior malignancy was reported in 22.5% of patients with LC. Chlamydia IgA and LC were statistically non-significantly associated regardless of the age of the patients. In one study, Chlamydia HP-60 IgG \u3e 1:50 was associated with significantly increased odds of LC in two respective models (ORs of 1.34 [95% CI 1.06–1.69] and 1.30 [95% CI 1.02–1.67]). A fourth study reported C. pneumoniae IgA \u3e 64 titers to be 58%, 29%, and 5.5% among patients with LC, without LC, and healthy blood donors, respectively. Conclusions: The incidence of LC was reported to range from 2.3% to 10.3% following an episode of pneumonia. There is limited evidence of the association of chronic Chlamydia infection with LC, and Chlamydia could be a causal cofactor of LC

OncoLog Volume 45, Number 11, November 2000

Program Addresses Medical, Psychosocial Needs of Young People with Cancer DiaLog: Coming of Age ... with Cancer, by Sima Jeha, MD, Medical Director, Adolescent and Young Adult Program House Call: Cancer Screening: Early Detection Does Make a Difference Endostatin: Phase I Trial Yields Promising Preliminary Results Molecular Radiosensitizers Target Proliferation and Apoptosis Pathways in Tumor Cellshttps://openworks.mdanderson.org/oncolog/1090/thumbnail.jp

Source and Sink Strength of Carbon Dioxide, Methane and Distribution of Sulfate in Salt-marsh Soils at the Wadden Sea Coast of Northern Germany

A field study was conducted at Schleswig-Holstein of Kiel in Germany to evaluate the factors controlling carbon and sulfate dynamics along a toposequence of coastal salt marsh soils. The soil at the top end of the salt marsh was salic silty to clayic Typic Sulfaquent (Salzrohmarsh) and the bottom end was sandy to silty Haplic Sulfaquent  Ubergangsmischwatt). The mean (depth: 0-100 cm) values of pH andrH were 6.8-6.9; 6.8-7.0 and 17.3-8.1; 15-8.6 for the Typic Sulfaquent (TS) and Haplic Sulfaquent (HS) throughout the year, respectively. The net-emission of CO2 was negative (-14.0 g m-2 yr-1) for the HS but highly positive (857 g m-2 yr-1) for the TS throughout the year. The annual emissions of CH4 were almost 10fold higher in HS (0.3 g m-2 yr-1) than that of the TS (0.03 g m-2 yr-1). The concentrations of CH4 at different seasons showed almost inverse relationships with the concentrations of CO2, varied significantly (p.0.05) with the seasons and depth function, and showed no dependence to temperature. The SO4 contents were observed maximum in the TS than that of HS during all the seasons. There was no noticeable correlation (r=-0.09) between SO4 and CH4 concentrations. Moreover, even CH4 was determined at depths where the SO4concentration was about 1200 mg SO4 L-

Impact of Vitamin D Supplementation on Arterial Vasomotion, Stiffness and Endothelial Biomarkers in Chronic Kidney Disease Patients

Background: Cardiovascular events are frequent and vascular endothelial function is abnormal in patients with chronic kidney disease (CKD). We demonstrated endothelial dysfunction with vitamin D deficiency in CKD patients; however the impact of cholecalciferol supplementation on vascular stiffness and vasomotor function, endothelial and bone biomarkers in CKD patients with low 25-hydroxy vitamin D [25(OH)D] is unknown, which this study investigated. Methods: We assessed non-diabetic patients with CKD stage 3/4, age 17–80 years and serum 25(OH)D ,75 nmol/L. Brachial artery Flow Mediated Dilation (FMD), Pulse Wave Velocity (PWV), Augmentation Index (AI) and circulating blood biomarkers were evaluated at baseline and at 16 weeks. Oral 300,000 units cholecalciferol was administered at baseline and 8-weeks. Results: Clinical characteristics of 26 patients were: age 50614 (mean61SD) years, eGFR 41611 ml/min/1.73 m2, males 73%, dyslipidaemia 36%, smokers 23% and hypertensives 87%. At 16-week serum 25(OH)D and calcium increased (43616 to 84629 nmol/L, p,0.001 and 2.3760.09 to 2.4260.09 mmol/L; p = 0.004, respectively) and parathyroid hormone decreased (10.868.6 to 7.464.4; p = 0.001). FMD improved from 3.163.3% to 6.163.7%, p = 0.001. Endothelial biomarker concentrations decreased: E-Selectin from 566662123 to 525662058 pg/mL; p = 0.032, ICAM-1, 3.4560.01 to 3.1061.04 ng/mL; p = 0.038 and VCAM-1, 54633 to 42633 ng/mL; p = 0.006. eGFR, BP, PWV, AI, hsCRP, von Willebrand factor and Fibroblast Growth Factor-23, remained unchanged. Conclusion: This study demonstrates for the first time improvement of endothelial vasomotor and secretory functions with vitamin D in CKD patients without significant adverse effects on arterial stiffness, serum calcium or FGF-23. Trial Registration: ClinicalTrials.gov NCT0200571

Von Bezold assimilation effect reverses in stereoscopic conditions

Lightness contrast and lightness assimilation are opposite phenomena: in contrast, grey targets appear darker when bordering bright surfaces (inducers) rather than dark ones; in assimilation, the opposite occurs. The question is: which visual process favours the occurrence of one phenomenon over the other? Researchers provided three answers to this question. The first asserts that both phenomena are caused by peripheral processes; the second attributes their occurrence to central processes; and the third claims that contrast involves central processes, whilst assimilation involves peripheral ones. To test these hypotheses, an experiment on an IT system equipped with goggles for stereo vision was run. Observers were asked to evaluate the lightness of a grey target, and two variables were systematically manipulated: (i) the apparent distance of the inducers; and (ii) brightness of the inducers. The retinal stimulation was kept constant throughout, so that the peripheral processes remained the same. The results show that the lightness of the target depends on both variables. As the retinal stimulation was kept constant, we conclude that central mechanisms are involved in both lightness contrast and lightness assimilation

A Four-Year Multi-Center Retrospective Observational Study of Pediatric Emergency Medical Services Utilization in a Large Metropolitan Health System

Study Objectives: The COVID-19 pandemic has significantly decreased pediatric emergency department (ED) utilization. The objective of this study was to quantify the characteristics of pediatric EMS utilization both before and during the COVID-19 pandemic in a metropolitan health care system. Methods: We performed a multi-center, retrospective observational study of all pediatric ED visits between 1/1/2018 and 12/31/2021, that presented to one of nine EDs within our health system. The data were sorted by mode of arrival; children arriving to the ED via EMS, or arrival by other means. Data collection included a variety of demographic and clinical variables. We compared overall pediatric ED patients’ arrival methods as well as ED and EMS volumes by year using a binomial test with a null hypothesis that the population proportion equals 50%. Analysis compared ED mode of arrival, admission rate, and Emergency Severity Index (ESI) triage scores using chi-square tests. Results: There were 201,313 pediatric ED encounters for 118,744 unique patients meeting the inclusion criteria. There were 8,815 (4.38%) children who arrived via EMS compared to 192,498 (95.62%) children who arrived by other means (p \u3c 0.0001). Children who arrived via EMS had a higher admission rate of 22.27% (1963) compared to 5.9% (11,351, p \u3c 0.0001). ESI among children arriving via EMS was higher, with 44.3% (3847) having ESI 1 or 2 triage scores compared to 8.8% (16,790) for children arriving by other means (p \u3c 0.0001). Overall pediatric ED mortality was 0.03% (61 deaths), with 86.9% (53) of those children arriving via EMS (p \u3c 0.0001). Pediatric ED and EMS volumes in 2018 and 2019 pre-pandemic were 127,652 ED visits and 5,306 EMS visits, respectively, compared to 73,661 and 3,509 visits in 2020 and 2021. This represents a 42.3% overall reduction in pediatric ED visits (p \u3c 0.0001) and a 33.9% reduction in pediatric EMS visits (p \u3c 0.0001). Conclusion: Approximately 5% of pediatric ED encounters in our health system arrived via EMS. These children appeared to have higher acuity presentations and required inpatient services more often than children who arrived by other means. Pediatric ED and EMS encounters have decreased substantially since the onset of the pandemic

Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor

Systemic lupus erythematosus is a polymorphic and multigenic inflammatory autoimmune disease. Cyclic AMP (cAMP) modulates inflammation and the inhibition of cyclic nucleotide phosphodiesterase type 4 (PDE4), which specifically hydrolyzes cAMP, inhibits TNFα secretion. This study was aimed at investigating the evolution of PDE activity and expression levels during the course of the disease in MRL/lpr lupus-prone mice, and to evaluate in these mice the biological and clinical effects of treatments with pentoxifylline, denbufylline and NCS 613 PDE inhibitors. This study reveals that compared to CBA/J control mice, kidney PDE4 activity of MRL/lpr mice increases with the disease progression. Furthermore, it showed that the most potent and selective PDE4 inhibitor NCS 613 is also the most effective molecule in decreasing proteinuria and increasing survival rate of MRL/lpr mice. NCS 613 is a potent inhibitor, which is more selective for the PDE4C subtype (IC50 = 1.4 nM) than the other subtypes (PDE4A, IC50 = 44 nM; PDE4B, IC50 = 48 nM; and PDE4D, IC50 = 14 nM). Interestingly, its affinity for the High Affinity Rolipram Binding Site is relatively low (Ki = 148 nM) in comparison to rolipram (Ki = 3 nM). Finally, as also observed using MRL/lpr peripheral blood lymphocytes (PBLs), NCS 613 inhibits basal and LPS-induced TNFα secretion from PBLs of lupus patients, suggesting a therapeutic potential of NCS 613 in systemic lupus. This study reveals that PDE4 represent a potential therapeutic target in lupus disease

In vivo imaging and quantitative analysis of leukocyte directional migration and polarization in inflamed tissue

Directional migration of transmigrated leukocytes to the site of injury is a central event in the inflammatory response. Here, we present an in vivo chemotaxis assay enabling the visualization and quantitative analysis of subtype-specific directional motility and polarization of leukocytes in their natural 3D microenvironment. Our technique comprises the combination of i) semi-automated in situ microinjection of chemoattractants or bacteria as local chemotactic stimulus, ii) in vivo near-infrared reflected-light oblique transillumination (RLOT) microscopy for the visualization of leukocyte motility and morphology, and iii) in vivo fluorescence microscopy for the visualization of different leukocyte subpopulations or fluorescence-labeled bacteria. Leukocyte motility parameters are quantified off-line in digitized video sequences using computer-assisted single cell tracking. Here, we show that perivenular microinjection of chemoattractants [macrophage inflammatory protein-1alpha (MIP-1alpha/Ccl3), platelet-activating factor (PAF)] or E. coli into the murine cremaster muscle induces target-oriented intravascular adhesion and transmigration as well as polarization and directional interstitial migration of leukocytes towards the locally administered stimuli. Moreover, we describe a crucial role of Rho kinase for the regulation of directional motility and polarization of transmigrated leukocytes in vivo. Finally, combining in vivo RLOT and fluorescence microscopy in Cx3CR1(gfp/gfp) mice (mice exhibiting green fluorescent protein-labeled monocytes), we are able to demonstrate differences in the migratory behavior of monocytes and neutrophils.Taken together, we propose a novel approach for investigating the mechanisms and spatiotemporal dynamics of subtype-specific motility and polarization of leukocytes during their directional interstitial migration in vivo